AA
CDMO

AlphaMark Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

AlphaMark Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15
Closed – – 842
2024
Q2 		$0 Buy
+15
New +$115 ﹤0.01% 850

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

AlphaMark Advisors's CDMO Position: Q3 2024 in Review

AlphaMark Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2024, closing a stake of 15 shares.

AlphaMark Advisors first reported a position in CDMO in Q2 2024 and held it in 1 quarter. The position peaked at $0 in Q2 2024. 171 funds tracked by Wall St. Rank hold CDMO as of Q3 2024.

  • AlphaMark Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • AlphaMark Advisors sold 15 Avid Bioservices, Inc. Common Stock shares in Q3 2024.
  • AlphaMark Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • AlphaMark Advisors's Avid Bioservices, Inc. Common Stock position peaked at $0 in Q2 2024.
  • 171 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2024.

Based on AlphaMark Advisors's 13F filing for Q3 2024, filed 16 Oct 2024.